Smart cuff helps cancer patients keep blood pressure in check

NCT ID NCT06364748

Completed Disease control Sponsor: West Michigan Cancer Center Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed trial tested whether a cellular-enabled blood pressure cuff, used at home, could help cancer patients on the drug bevacizumab better track and manage high blood pressure. Twenty participants were randomly assigned to use the smart cuff or a standard cuff. The goal was to see if remote monitoring improves how often patients check their blood pressure and how quickly doctors can respond to dangerous readings.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Cellular-enabled blood pressure cuff
What this could lead to: If successful, this approach could make it easier for cancer patients to monitor their blood pressure at home and catch dangerous spikes early.
What could go wrong: This was a very small, completed trial with only 20 participants, so results may not apply to all patients. The technology depends on patient ability to use the cuff correctly.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hypertensive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HYPERTENSION

Contacts and locations

Locations

West Michigan Cancer Center

Kalamazoo, Michigan, 49007, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.